Eyedrops for Diabetic Retinopathy Possible in the Future?

Source: Medscape

Early topical treatment for diabetic retinopathy may be possible in the future, at least for a subset of diabetes patients, new trial results suggest, according to a report in Medscape.

Findings from the European Consortium for the Early Treatment of Diabetic Retinopathy (EUROCONDOR) were presented September 13 at the European Association for the Study of Diabetes (EASD) 2017 Annual Meeting by Rafael Simó, MD, head of diabetes and metabolism at Vall d'Hebron Research Institute, Barcelona, Spain.

The 2-year randomized trial compared the effects of twice-daily eyedrops containing the neuroprotective agents somatostatin or brimonidine against placebo drops for arresting neurodegeneration and for effects on a variety of retinal and visual outcomes.

Read the full article here.

Related Content